BioIndiana
Filter News
Found 1,264 articles
-
Despite the changing landscape in biopharma, many companies are still recruiting. If you’re looking to make a career change, here are 12 biopharma companies hiring on BioSpace now.
-
Elanco to Participate in Upcoming Investor Conferences
2/22/2024
Elanco Animal Health Incorporated (NYSE: ELAN) today announced that the Company will participate in the following investor conferences.
-
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2024
2/21/2024
Zimmer Biomet Holdings, Inc. today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the first quarter of 2024.
-
Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M
2/13/2024
Sudo Biosciences today announced that during January 2024, it completed a second close of its Series B financing, raising an additional $30 million from new investors Dementia Discovery Fund.
-
Zimmer Biomet Signs Global Health Equity Network's Zero Health Gaps Pledge and Expands Longstanding Commitment to Advancing Health Equity
2/12/2024
Zimmer Biomet Holdings, Inc. signed the Global Health Equity Network's (GHEN) Zero Health Gaps Pledge , a commitment from CEOs across industries and regions for their organizations to embed health equity in core strategies, operations and investments.
-
Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting
2/12/2024
Zimmer Biomet Holdings, Inc. today announced that it is showcasing the latest innovations across its product portfolio at the 2024 annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) this week in San Francisco.
-
Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results
2/8/2024
Zimmer Biomet Announces Fourth Quarter and Full-Year 2023 Financial Results.
-
MBX Biosciences Appoints Steven Ryder, M.D., to Board of Directors
2/5/2024
MBX Biosciences, Inc. today announced the appointment of Steven Ryder, M.D., Chief Medical Officer of Rallybio, to its Board of Directors.
-
MBX Biosciences to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
1/31/2024
MBX Biosciences, Inc. today announced that Kent Hawryluk, President and Chief Executive Officer, will present at the virtual Oppenheimer 34th Annual Healthcare Life Sciences Conference on Wednesday, February 14th , 2024, at 12:40 p.m. ET.
-
Gate Neurosciences Announces Clinical Collaboration with Beacon Biosignals to Advance Precision EEG Biomarkers in Major Depressive Disorder
1/24/2024
Gate Neurosciences today announced a strategic collaboration with Beacon Biosignals to further advance the use of electroencephalogram (EEG) biomarkers across the company’s clinical pipeline in neuropsychiatry and cognition.
-
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2023 Financial Results
1/16/2024
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Thursday, February 8, 2024 at 8:30 a.m. ET.
-
DecisionRx Announces $100 Million Credit Facility with Carlyle
1/11/2024
DecisionRx, Inc. today announced that it has entered into a $100 million credit facility with global investment firm Carlyle.
-
Zimmer Biomet Announces Appointment of Louis A. Shapiro to Board of Directors
1/5/2024
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Louis A. Shapiro , formerly the President and Chief Executive Officer of the Hospital for Special Surgery (HSS), has been appointed to the Board, effective immediately.
-
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™
1/4/2024
Eli Lilly and Company (NYSE: LLY) today announced LillyDirect ™, a new digital healthcare experience for patients in the U.S. living with obesity, migraine and diabetes.
-
Lilly to Participate in J.P. Morgan Healthcare Conference - January 2, 2024
1/2/2024
Eli Lilly and Company (NYSE: LLY) will attend the 42nd Annual J.P. Morgan Healthcare Conference, Jan. 8-11 , 2024.
-
Zimmer Biomet to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/19/2023
Zimmer Biomet Holdings, Inc. today announced that members of the Zimmer Biomet management team will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 , at 8:15 a.m. PT ( 11:15 a.m. ET ).
-
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
12/18/2023
Lantheus Holdings, Inc. today announced statistically significant topline results from the pivotal phase 3 SPLASH study evaluating the efficacy and safety of 177 Lu-PNT2002, a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT).
-
Claris GenomiX Looks to Transform Precision Oncology Through Its Groundbreaking mRNA-Based Diagnostics
12/12/2023
Claris GenomiX Looks to Transform Precision Oncology Through Its Groundbreaking mRNA-Based Diagnostics.
-
First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent
12/11/2023
Telix Pharmaceuticals Limited today announces that the first patient has been dosed in a United States (U.S.) expanded access program (EAP, ClinicalTrials.gov ID: NCT06090331 ) for TLX250-CDx ( 89 Zr-DFO-girentuximab).
-
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023
12/4/2023
Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares ("Shares") of common stock of POINT Biopharma Global Inc.